Status:
TERMINATED
Recovernow: Tablet-Based Speech Therapy For Post-Stroke Aphasia
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Stroke Sequelae
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
RECOVERNOW is A MULTICENTRE PHASE II RANDOMIZED CONTROLLED TRIAL OF EARLY MOBILE TABLET-BASED SPEECH THERAPY FOR ACUTE STROKE PATIENTS WITH APHASIA. Using a novel futility design, investigators will r...
Detailed Description
Post-stroke aphasia is a major cause of disability. Aphasia is a heterogeneous condition and can manifest in a variety of communication impairments, including difficulty producing words or sentences a...
Eligibility Criteria
Inclusion
- diagnosis of ischemic/hemorrhagic stroke documented with CT and/or MRI and,
- mild to moderate aphasia, and/or -) Scoring ≥ 1 on the Best Language parameters of the National Institute of Health Stroke Score (NIHSS).
Exclusion
- Pre-existing speech, language or cognitive disorders (such as dementia, mild cognitive impairment),
- severe debilitating disease(s) that, in the opinion of the investigator, would preclude them from being able to complete the study to follow-up (ex: end-stage malignancy, ALS),
- Severe comprehension deficits (unable to follow simple one-step commands and/or unable to respond to yes/no questions reliably), and
- English is not the primary language
- subarachnoid, subdural and epidural hemorrhages.
Key Trial Info
Start Date :
November 13 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 11 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03755063
Start Date
November 13 2019
End Date
April 11 2022
Last Update
April 19 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9
2
University Health Network / University of Toronto
Toronto, Ontario, Canada, M5G 2C4